by Team PCM | Mar 22, 2024 | Blog Post, Pharmacy Benefits
Pharmacy Benefits The Impact of Biosimilars and Generic Alternatives to Specialty Drug Management By Team PCM | March 22, 2023 | Blog post, Pharmacy Benefits, Plan Management Most Recent Post The Impact of Biosimilars and Generic Alternatives on Specialty Drug...
by Team PCM | Feb 29, 2024 | Blog Post, Contract Management, Data Analytics, Pharmacy Benefits, Plan Management
Contract Management Contract and Claim Analysis: Helping Fiduciaries Manage Plan Assets Appropriately By Team PCM | Feb 29, 2024 | Blog post, Contract Management, Plan Management Most Recent Post Contract and Claim Analysis: Helping Fiduciaries Manage Plan Assets...
by Team PCM | Jan 24, 2024 | Blog Post, Pharmacy Benefits, Plan Management
Plan Management 2024 Will See Higher than Normal Employer Health Cost Increases – What Actions Can You Take to Control Costs? By Team PCM | Jan 24, 2023 | Blog post, Pharmacy Benefits, Plan Management Most Recent Post 2024 Will See Higher than Normal Employer...
by Team PCM | Nov 27, 2023 | Blog Post, Pharmacy Benefits, Plan Management
Pharmacy Benefits Pharmacist: Biosimilar Adoption Impacts Patients and Plans in 2024 By Team PCM | Nov 27, 2023 | Blog post, Pharmacy Benefits, Plan Management Most Recent Post 2024 Will See Higher than Normal Employer Health Cost Increases – What Actions Can You Take...
by Team PCM | Oct 24, 2023 | Blog Post, Contract Management, Pharmacy Benefits, Plan Management
Drug rebates refer to financial agreements between pharmaceutical manufacturers and payers, such as self-insured employer plans or pharmacy benefit managers (PBMs). These agreements involve a portion of the purchase price of a medication returned to the payer as a...
by Team PCM | Sep 8, 2023 | Blog Post, Contract Management
Benefits consultants face significant challenges when managing pharmacy benefit spend for clients. The lengthy process of evaluating Pharmacy Benefit Management (PBM) contracts for large employers often leaves limited time and resources for mid-market groups,...